Klaus Schmierer, MB BS, PhD, FRCP, discusses how patients with multiple sclerosis have been impacted by the COVID-19 pandemic, including guideline recommendations regarding vaccinations.
EP. 1: Pathophysiology of Multiple Sclerosis (MS)
Klaus Schmierer, MB BS, PhD, FRCP, defines the pathophysiology of multiple sclerosis (MS).
EP. 2: Disease-Modifying Therapies (DMT) and the Immune System
Dr Schmierer introduces the disease-modifying therapies (DMT) that are available for patients with MS and their impact on the immune system.
EP. 3: SARS-CoV-2, COVID-19 Vaccine, and MS
Dr Schmierer explains how the SARS-CoV-2 infection and COVID-19 pandemic have impacted treating patients with MS with DMTs.
EP. 4: MS Immune Responses to COVID-19 Vaccines
An expert delves into the different types of immune responses a patient with MS can have to COVID-19 vaccines if they are also on DMTs.
EP. 5: MS Guideline Recommendations for Vaccines
Dr Schmierer discusses the general guideline vaccination recommendations for patients with MS.
EP. 6: MS COVID-19/Vaccine Advice
Klaus Schmierer, MB BS, PhD, FRCP, concludes with advice for community physicians and neurologists who are managing patients with MS and COVID-19 or vaccinations.
2 Clarke Drive Cranbury, NJ 08512